WO2014172653A3 - Anti-notch1 antibodies - Google Patents
Anti-notch1 antibodies Download PDFInfo
- Publication number
- WO2014172653A3 WO2014172653A3 PCT/US2014/034673 US2014034673W WO2014172653A3 WO 2014172653 A3 WO2014172653 A3 WO 2014172653A3 US 2014034673 W US2014034673 W US 2014034673W WO 2014172653 A3 WO2014172653 A3 WO 2014172653A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- notch1
- antibodies
- notch1 antibodies
- disorders
- bind
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Abstract
Monoclonal antibodies that bind and inhibit biological activities of human Notch1 are disclosed. The antibodies can be used to treat cell proliferative diseases and disorders, including certain forms of cancer, associated with activation or over-expression of Notch1.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361814168P | 2013-04-19 | 2013-04-19 | |
US61/814,168 | 2013-04-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2014172653A2 WO2014172653A2 (en) | 2014-10-23 |
WO2014172653A3 true WO2014172653A3 (en) | 2015-01-08 |
Family
ID=50942790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2014/034673 WO2014172653A2 (en) | 2013-04-19 | 2014-04-18 | Anti-notch1 antibodies |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2014172653A2 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008091641A2 (en) * | 2007-01-24 | 2008-07-31 | Oncomed Pharmaceuticals, Inc. | Compositions and methods for diagnosing and treating cancer |
WO2008150525A1 (en) * | 2007-06-04 | 2008-12-11 | Genentech, Inc. | Anti-notch1 nrr antibodies and methods using same |
WO2010059543A1 (en) * | 2008-11-20 | 2010-05-27 | Merck Sharp & Dohme Corp. | Generation and characterization of anti-notch antibodies for therapeutic and diagnostic use |
WO2011088215A2 (en) * | 2010-01-13 | 2011-07-21 | Oncomed Pharmaceuticals, Inc. | Notch1 binding agents and methods of use thereof |
WO2012003472A1 (en) * | 2010-07-02 | 2012-01-05 | Aveo Pharmaceuticals, Inc. | Anti-notch1 antibodies |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060222590A1 (en) | 2005-04-05 | 2006-10-05 | Murray Robinson | Directed complementation |
-
2014
- 2014-04-18 WO PCT/US2014/034673 patent/WO2014172653A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008091641A2 (en) * | 2007-01-24 | 2008-07-31 | Oncomed Pharmaceuticals, Inc. | Compositions and methods for diagnosing and treating cancer |
WO2008150525A1 (en) * | 2007-06-04 | 2008-12-11 | Genentech, Inc. | Anti-notch1 nrr antibodies and methods using same |
WO2010059543A1 (en) * | 2008-11-20 | 2010-05-27 | Merck Sharp & Dohme Corp. | Generation and characterization of anti-notch antibodies for therapeutic and diagnostic use |
WO2011088215A2 (en) * | 2010-01-13 | 2011-07-21 | Oncomed Pharmaceuticals, Inc. | Notch1 binding agents and methods of use thereof |
WO2012003472A1 (en) * | 2010-07-02 | 2012-01-05 | Aveo Pharmaceuticals, Inc. | Anti-notch1 antibodies |
Also Published As
Publication number | Publication date |
---|---|
WO2014172653A2 (en) | 2014-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011143318A3 (en) | Anti-fgfr2 antibodies | |
PH12015500114B1 (en) | HUMAN ANTIBODIES TO GFRa3 AND METHODS OF USE THEREOF | |
MX2015007751A (en) | Anti-gdf15 antibodies. | |
MX2018001532A (en) | Anti-angptl8 antibodies and uses thereof. | |
PH12016500781A1 (en) | Novel anti-claudin antibodies and methods of use | |
WO2014197849A3 (en) | Anti-c10orf54 antibodies and uses thereof | |
WO2014159595A3 (en) | Human antibodies to nav1.7 | |
NZ733055A (en) | Anti-c10orf54 antibodies and uses thereof | |
MX2016003129A (en) | Combination therapy of antibodies against human csf-1r and antibodies against human pd-l1. | |
WO2017031458A3 (en) | Anti-dll3 antibody drug conjugates and methods of use | |
EA201991214A1 (en) | ANTIBODIES AGAINST PD-1 AND THEIR COMPOSITION | |
PH12016501109A1 (en) | Novel anti-dpep3 antibodies and methods of use | |
AU2013216320A8 (en) | C10RF32 Antibodies, And Uses Thereof For Treatment Of Cancer | |
WO2013177055A3 (en) | ANTI-Ly6E ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE | |
WO2012145183A3 (en) | Combinations of anti-4-1bb antibodies and adcc-inducing antibodies for the treatment of cancer | |
MX2015013166A (en) | Dual specific binding proteins directed against il-1 beta and il-17. | |
WO2015050959A8 (en) | Anti-kit antibodies and methods of use thereof | |
WO2014108484A3 (en) | Combination therapy of anti-her3 and anti-her2 antibodies | |
NZ720769A (en) | Anti-siglec-8 antibodies and methods of use thereof | |
TN2019000086A1 (en) | Anti-il-33 antibodies and uses thereof | |
MX2014001766A (en) | Neuregulin antibodies and uses thereof. | |
MX2015008534A (en) | ANTI- INTEGRIN ß1 ANTIBODY COMPOSITIONS AND METHODS OF USE THEREOF. | |
WO2011156617A3 (en) | Anti-egfr antibodies | |
MX2015015232A (en) | Monoclonal antibody directed against cxcr5. | |
EP3502141A4 (en) | Antibody targeted to tissue factor, preparation method therefor, and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14730253 Country of ref document: EP Kind code of ref document: A2 |